Minghuan Jiang
Overview
Explore the profile of Minghuan Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao X, Fu M, Peng J, Feng D, Ma Y, Wu Y, et al.
Hum Vaccin Immunother
. 2025 Jan;
21(1):2444008.
PMID: 39773178
Parental vaccine hesitancy is a major obstacle to childhood vaccination. We examined parental socioeconomic status (SES) disparities in vaccine hesitancy, and the potential mediating roles of perceived social support and...
2.
Jiang M, Zhang H, Yao X, Wang Y, Lai X, Fang H
Vaccine
. 2024 Aug;
42(25):126150.
PMID: 39095276
Background: In late 2022, China became the first country to roll out mucosal COVID-19 vaccines. No prior study has yet compared the immunization stress-related responses (ISRR) among different routes of...
3.
Zhou L, Jiang M, Duan R, Zuo F, Li Z, Xu S
JMIR Mhealth Uhealth
. 2024 Jan;
12:e48842.
PMID: 38261368
Background: 5G technology is gaining traction in Chinese hospitals for its potential to enhance patient care and internal management. However, various barriers hinder its implementation in clinical settings, and studies...
4.
Yao X, Peng J, Ma Y, Fu M, Fang Y, Fang H, et al.
Vaccine
. 2023 Oct;
41(46):6870-6877.
PMID: 37821318
Objective: Vaccine hesitancy is a primary factor that influences vaccine uptake; however, no specific measurement tool to accurately assess vaccine hesitancy is available in China. This study aimed to develop...
5.
Ma Y, Peng J, Yao X, Feng L, Shi X, Jiang M
Front Public Health
. 2023 Jun;
11:1182617.
PMID: 37275477
Objective: We aimed to evaluate the accessibility of anticancer medicines in public hospitals of Shaanxi, a representative province of Northwestern China. Methods: Thirty-one anticancer medicines were investigated in 146 designated...
6.
Jiang M, Yao X, Peng J, Feng L, Ma Y, Shi X, et al.
Am J Prev Med
. 2023 May;
65(5):818-826.
PMID: 37182556
Introduction: Adjuvanted recombinant zoster vaccine (RZV) was the first vaccine made available for herpes zoster in China. Authors aimed to evaluate its economic and health impacts on Chinese adults aged...
7.
Gong Y, Yao X, Peng J, Ma Y, Fang Y, Yan K, et al.
Am J Prev Med
. 2023 Apr;
65(1):155-164.
PMID: 37037733
Introduction: Authors aimed to evaluate the economic and health impacts of three influenza vaccines available in China, including trivalent inactivated vaccine, quadrivalent inactivated vaccine, and live attenuated influenza vaccine, for...
8.
Fang H, Chen C, Fang Y, He X, Hou Z, Jiang M, et al.
Hum Vaccin Immunother
. 2022 Oct;
18(6):2132802.
PMID: 36287462
This study aimed to develop a consensus framework for economic evaluations of vaccines as a national guideline in China. Some unique and important aspects were particularly emphasized. Nineteen Chinese experts...
9.
Yang R, Kabba J, Yao X, Yang C, Chang J, Ji W, et al.
Front Pharmacol
. 2022 Sep;
13:911165.
PMID: 36071832
The biomedical industry has grown significantly both globally and in China; however, there are still challenges. This study aimed at evaluating the biopharmaceutical sector of China, in terms of ability...
10.
Jiang M, Yao X, Li P, Fang Y, Feng L, Hayat K, et al.
BMC Public Health
. 2022 Jun;
22(1):1128.
PMID: 35668438
Background: Influenza vaccination coverage rate among the elderly is low in China. We aimed to evaluate the impact of video-led educational intervention on influenza vaccine uptake among the Chinese elderly....